Flagship Pioneering as of June 30, 2021
Portfolio Holdings for Flagship Pioneering
Flagship Pioneering holds 12 positions in its portfolio as reported in the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Moderna (MRNA) | 61.8 | $4.8B | 21M | 234.98 | |
| Rubius Therapeutics | 12.0 | $940M | 39M | 24.41 | |
| Sana Biotechnology (SANA) | 8.6 | $673M | 34M | 19.66 | |
| Seres Therapeutics | 4.4 | $343M | 14M | 23.85 | |
| Evelo Biosciences | 4.0 | $316M | 23M | 13.74 | |
| Denali Therapeutics (DNLI) | 2.7 | $214M | 2.7M | 78.44 | |
| Kaleido Biosciences Ord (KLDO) | 1.9 | $146M | 20M | 7.44 | |
| Foghorn Therapeutics (FHTX) | 1.7 | $135M | 13M | 10.67 | |
| Sigilon Therapeutics | 1.4 | $111M | 10M | 10.73 | |
| Axcella Health Inc equity | 0.6 | $50M | 13M | 4.01 | |
| Codiak Biosciences | 0.6 | $48M | 2.6M | 18.53 | |
| Syros Pharmaceuticals | 0.2 | $16M | 2.9M | 5.45 |
